After Abbott (NYSE: ABT) reported earnings we noted that Dexcom (NASDAQ: DXCM) would not sit around and do nothing, that they would find a way to fight back. Well the fight has begun as Dexcom along with OmniPod maker Insulet (NASDAQ: PODD) announced a program to entice Animas patients to switch to the OmniPod system. Now the patients who convert to the OmniPod will receive a $200 gift card that can used towards the purchase of Dexcom’s G5 system.
For the moment Dexcom has not announced a similar program with their other insulin pump partner Tandem (NASDAQ: TNDM) who . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.